TY - JOUR
T1 - Risk Factors and Cancer Screening in Myositis
AU - Moghadam-Kia, Siamak
AU - Oddis, Chester V.
AU - Ascherman, Dana P.
AU - Aggarwal, Rohit
PY - 2020/8
Y1 - 2020/8
N2 - The idiopathic inflammatory myopathies, particularly dermatomyositis, are associated with an increased risk of cancer. Lung, ovarian, breast, colon, prostate, and cervical cancers, and hematologic malignancies, are among the most common associated cancers. Risk stratification for cancer in patients with myositis is based on clinical risk factors/red flags, myositis clinical subtypes, and myositis-specific autoantibodies. Clinical risk factors include older age at disease onset, male gender, dysphagia, acute onset/refractory myositis, cutaneous ulceration, necrosis/vasculitis, and elevated inflammatory markers. Appropriate screening strategies are based on the risk level. Further studies are warranted to determine the role of advanced imaging and comprehensive cancer screening.
AB - The idiopathic inflammatory myopathies, particularly dermatomyositis, are associated with an increased risk of cancer. Lung, ovarian, breast, colon, prostate, and cervical cancers, and hematologic malignancies, are among the most common associated cancers. Risk stratification for cancer in patients with myositis is based on clinical risk factors/red flags, myositis clinical subtypes, and myositis-specific autoantibodies. Clinical risk factors include older age at disease onset, male gender, dysphagia, acute onset/refractory myositis, cutaneous ulceration, necrosis/vasculitis, and elevated inflammatory markers. Appropriate screening strategies are based on the risk level. Further studies are warranted to determine the role of advanced imaging and comprehensive cancer screening.
KW - Cancer screening
KW - Dermatomyositis
KW - Idiopathic inflammatory myopathies
UR - http://www.scopus.com/inward/record.url?scp=85085917081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085917081&partnerID=8YFLogxK
U2 - 10.1016/j.rdc.2020.05.006
DO - 10.1016/j.rdc.2020.05.006
M3 - Review article
C2 - 32631604
AN - SCOPUS:85085917081
VL - 46
SP - 565
EP - 576
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
SN - 0889-857X
IS - 3
ER -